Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is to evaluate the effectiveness and safety of a new investigational
dur, IC351. Study is designed to gather information regarding the possible usefulness of
IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud
phenomenon as well as the vaginal dryness and discomfort associated with scleroderma
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey